Abstract
Any malignancy, mainly hematological, may be sensitive (with complete remission) to high-dose chemo and/or radiotherapy. The dose of most antineoplastic agents is limited by the toxicity to the normal marrow. The availability of marrow for transplantation (allogenic, syngenic or autologous), and the capability of reconstituting hematopoietic function, makes it possible to administer chemoradiotherapy in supralethal doses in an effort to kill a greater fraction of the malignant cells. Total Body Irradiation is used both to eradicate the malignant cells and to suppress host immune reactivity enough to prevent rejection of allogenic marrow. The transplanted allogenic marrow can also exert an antitumor effect. A survey of radiobiological studies undertaken is presented and preliminary results of a series of patients treated with TBI at ISSR are discussed.
| Original language | Italian |
|---|---|
| Pages (from-to) | 705-714 |
| Number of pages | 10 |
| Journal | Radiologia Medica |
| Volume | 72 |
| Issue number | 10 |
| Publication status | Published - Oct 1986 |
Fingerprint
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
Irradiazione corporea totale e trapianto di midollo osseo. / Martinenghi, C.; Villa, E.; Fossati, V.; Beatrice, S.
In: Radiologia Medica, Vol. 72, No. 10, 10.1986, p. 705-714.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Irradiazione corporea totale e trapianto di midollo osseo.
AU - Martinenghi, C.
AU - Villa, E.
AU - Fossati, V.
AU - Beatrice, S.
PY - 1986/10
Y1 - 1986/10
N2 - Any malignancy, mainly hematological, may be sensitive (with complete remission) to high-dose chemo and/or radiotherapy. The dose of most antineoplastic agents is limited by the toxicity to the normal marrow. The availability of marrow for transplantation (allogenic, syngenic or autologous), and the capability of reconstituting hematopoietic function, makes it possible to administer chemoradiotherapy in supralethal doses in an effort to kill a greater fraction of the malignant cells. Total Body Irradiation is used both to eradicate the malignant cells and to suppress host immune reactivity enough to prevent rejection of allogenic marrow. The transplanted allogenic marrow can also exert an antitumor effect. A survey of radiobiological studies undertaken is presented and preliminary results of a series of patients treated with TBI at ISSR are discussed.
AB - Any malignancy, mainly hematological, may be sensitive (with complete remission) to high-dose chemo and/or radiotherapy. The dose of most antineoplastic agents is limited by the toxicity to the normal marrow. The availability of marrow for transplantation (allogenic, syngenic or autologous), and the capability of reconstituting hematopoietic function, makes it possible to administer chemoradiotherapy in supralethal doses in an effort to kill a greater fraction of the malignant cells. Total Body Irradiation is used both to eradicate the malignant cells and to suppress host immune reactivity enough to prevent rejection of allogenic marrow. The transplanted allogenic marrow can also exert an antitumor effect. A survey of radiobiological studies undertaken is presented and preliminary results of a series of patients treated with TBI at ISSR are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0022793629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022793629&partnerID=8YFLogxK
M3 - Articolo
C2 - 3534969
AN - SCOPUS:0022793629
VL - 72
SP - 705
EP - 714
JO - Radiologia Medica
JF - Radiologia Medica
SN - 0033-8362
IS - 10
ER -